FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

716122004: Blinatumomab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3304745011 Blinatumomab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3304746012 Blinatumomab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Blinatumomab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Blinatumomab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing blinatumomab Has active ingredient True Blinatumomab Inferred relationship Existential restriction modifier 1
Product containing blinatumomab in parenteral dose form (medicinal product form) Has active ingredient True Blinatumomab Inferred relationship Existential restriction modifier 1
Blinatumomab Has active ingredient True Blinatumomab Inferred relationship Existential restriction modifier 1
Product containing only blinatumomab in parenteral dose form (medicinal product form) Has active ingredient True Blinatumomab Inferred relationship Existential restriction modifier 1
Product containing precisely blinatumomab 38.5 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Blinatumomab Inferred relationship Existential restriction modifier 1
Product containing precisely blinatumomab 38.5 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Blinatumomab Inferred relationship Existential restriction modifier 1
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Has specific active ingredient True Blinatumomab Inferred relationship Existential restriction modifier
Blincyto 38.5micrograms powder and solvent for solution for infusion vials (Amgen Ltd) Has specific active ingredient True Blinatumomab Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials 1 vial Has specific active ingredient True Blinatumomab Inferred relationship Existential restriction modifier
Blincyto 38.5micrograms powder and solvent for solution for infusion vials (Amgen Ltd) 1 vial Has specific active ingredient True Blinatumomab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start